295 related articles for article (PubMed ID: 23009155)
21. Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4
Zmajkovicova K; Pawar S; Maier-Munsa S; Maierhofer B; Wiest I; Skerlj R; Taveras AG; Badarau A
Genes Immun; 2022 Sep; 23(6):196-204. PubMed ID: 36089616
[TBL] [Abstract][Full Text] [Related]
22. The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.
Kallikourdis M; Trovato AE; Anselmi F; Sarukhan A; Roselli G; Tassone L; Badolato R; Viola A
Blood; 2013 Aug; 122(5):666-73. PubMed ID: 23794067
[TBL] [Abstract][Full Text] [Related]
23. Genetics on a WHIM.
Al Ustwani O; Kurzrock R; Wetzler M
Br J Haematol; 2014 Jan; 164(1):15-23. PubMed ID: 24111611
[TBL] [Abstract][Full Text] [Related]
24. WHIM syndrome: Immunopathogenesis, treatment and cure strategies.
McDermott DH; Murphy PM
Immunol Rev; 2019 Jan; 287(1):91-102. PubMed ID: 30565238
[TBL] [Abstract][Full Text] [Related]
25. CXCR4 WHIM syndrome is a cancer predisposition condition for virus-induced malignancies.
Moulin C; Beaupain B; Suarez F; Bertrand Y; Beaussant SC; Fischer A; Durin J; Ranta D; Espéli M; Bachelerie F; Bellanné-Chantelot C; Molina T; Emile JF; Balabanian K; Deback C; Donadieu J
Br J Haematol; 2024 Apr; 204(4):1383-1392. PubMed ID: 38442908
[TBL] [Abstract][Full Text] [Related]
26. Periodontal disease in patients with WHIM syndrome.
Brenchley L; McDermott DH; Gardner PJ; Silva LM; Gao JL; Cho E; Velez D; Moutsopoulos NM; Murphy PM; Fraser D
J Clin Periodontol; 2024 Apr; 51(4):464-473. PubMed ID: 38185798
[TBL] [Abstract][Full Text] [Related]
27. [WHIM syndrome: a case report and literature review].
Chen XJ; Yang WY; Wang SC; Guo Y; Liu F; Qi BQ; Chang LX; Zhou JF; An WB; Wei W; Wan Y; Zhu XF
Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):178-82. PubMed ID: 23751577
[TBL] [Abstract][Full Text] [Related]
28. Plerixafor for the Treatment of WHIM Syndrome.
McDermott DH; Pastrana DV; Calvo KR; Pittaluga S; Velez D; Cho E; Liu Q; Trout HH; Neves JF; Gardner PJ; Bianchi DA; Blair EA; Landon EM; Silva SL; Buck CB; Murphy PM
N Engl J Med; 2019 Jan; 380(2):163-170. PubMed ID: 30625055
[TBL] [Abstract][Full Text] [Related]
29. Plerixafor on a WHIM - Promise or Fantasy of a New CXCR4 Inhibitor for This Rare, but Important Syndrome?
Merati N; Sivachandran S; Jfri A; Ben-Shoshan M; Vinh DC; Popradi G; Litvinov IV
Skin Therapy Lett; 2022 Mar; 27(2):1-5. PubMed ID: 35385630
[TBL] [Abstract][Full Text] [Related]
30. Severe CD8+ T Lymphopenia in WHIM Syndrome Caused by Selective Sequestration in Primary Immune Organs.
Majumdar S; Pontejo SM; Jaiswal H; Gao JL; Salancy A; Stassenko E; Yamane H; McDermott DH; Balabanian K; Bachelerie F; Murphy PM
J Immunol; 2023 Jun; 210(12):1913-1924. PubMed ID: 37133343
[TBL] [Abstract][Full Text] [Related]
31. WHIM syndrome: congenital immune deficiency disease.
Kawai T; Malech HL
Curr Opin Hematol; 2009 Jan; 16(1):20-6. PubMed ID: 19057201
[TBL] [Abstract][Full Text] [Related]
32. A Sherlock Approach to a Kindred With a Variable Immunohematologic Phenotype.
Walkovich K; Grunebaum E
J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1714-1722. PubMed ID: 35470097
[TBL] [Abstract][Full Text] [Related]
33. Adaptive Immunodeficiency in WHIM Syndrome.
Majumdar S; Murphy PM
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577453
[TBL] [Abstract][Full Text] [Related]
34. Clinical and Hematologic Effects of Endotoxin in Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome Model Mice.
Majumdar S; Gao JL; Pontejo SM; Balabanian K; Bachelerie F; Murphy PM
Immunohorizons; 2022 Jul; 6(7):543-558. PubMed ID: 35882421
[TBL] [Abstract][Full Text] [Related]
35. A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.
McDermott DH; Velez D; Cho E; Cowen EW; DiGiovanna JJ; Pastrana DV; Buck CB; Calvo KR; Gardner PJ; Rosenzweig SD; Stratton P; Merideth MA; Kim HJ; Brewer C; Katz JD; Kuhns DB; Malech HL; Follmann D; Fay MP; Murphy PM
J Clin Invest; 2023 Oct; 133(19):. PubMed ID: 37561579
[TBL] [Abstract][Full Text] [Related]
36. Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors.
Gómez-Moutón C; Fischer T; Peregil RM; Jiménez-Baranda S; Stossel TP; Nakamura F; Mañes S
Blood; 2015 Feb; 125(7):1116-25. PubMed ID: 25355818
[TBL] [Abstract][Full Text] [Related]
37. CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.
de Wit RH; Heukers R; Brink HJ; Arsova A; Maussang D; Cutolo P; Strubbe B; Vischer HF; Bachelerie F; Smit MJ
J Pharmacol Exp Ther; 2017 Oct; 363(1):35-44. PubMed ID: 28768817
[TBL] [Abstract][Full Text] [Related]
38. Generalized verrucosis in a patient with GATA2 deficiency.
West ES; Kingsbery MY; Mintz EM; Hsu AP; Holland SM; Rady PL; Tyring SK; Grossman ME
Br J Dermatol; 2014 May; 170(5):1182-6. PubMed ID: 24359037
[TBL] [Abstract][Full Text] [Related]
39. WHIM Syndrome Caused by Waldenström's Macroglobulinemia-Associated Mutation CXCR4 (L329fs).
Liu Q; Pan C; Lopez L; Gao J; Velez D; Anaya-O'Brien S; Ulrick J; Littel P; Corns JS; Ellenburg DT; Malech HL; Murphy PM; McDermott DH
J Clin Immunol; 2016 May; 36(4):397-405. PubMed ID: 27059040
[TBL] [Abstract][Full Text] [Related]
40. Cxcr4-haploinsufficient bone marrow transplantation corrects leukopenia in an unconditioned WHIM syndrome model.
Gao JL; Yim E; Siwicki M; Yang A; Liu Q; Azani A; Owusu-Ansah A; McDermott DH; Murphy PM
J Clin Invest; 2018 Aug; 128(8):3312-3318. PubMed ID: 29715199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
